tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BLTE Stock Latest News

Belite Bio Advances in Retinal Disease Therapeutics
Company AnnouncementsBelite Bio Advances in Retinal Disease Therapeutics
17h ago
BLTE
Belite Bio Announces Q3 2025 Results and Key Trial Progress
PremiumCompany Announcements
Belite Bio Announces Q3 2025 Results and Key Trial Progress
1d ago
6K
BLTE
Belite Bio reports Q3 EPS (65c), consensus (49c)
PremiumThe Fly
Belite Bio reports Q3 EPS (65c), consensus (49c)
1d ago
BLTE
Belite Bio, Inc. ADR (BLTE) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Belite Bio, Inc. ADR (BLTE) Q3 Earnings Cheat Sheet
4d ago
BLTE
Belite Bio announces U.K.’s MHRA accepts CMA application for Tinlarebant
PremiumThe Fly
Belite Bio announces U.K.’s MHRA accepts CMA application for Tinlarebant
9d ago
BLTE
Belite Bio price target raised to $132 from $80 at Benchmark
PremiumThe FlyBelite Bio price target raised to $132 from $80 at Benchmark
11d ago
BLTE
Belite Bio management to meet virtually with Cantor
Premium
The Fly
Belite Bio management to meet virtually with Cantor
14d ago
BLTE
Belite Bio management to meet virtually with Cantor
Premium
The Fly
Belite Bio management to meet virtually with Cantor
19d ago
BLTE
Belite Bio files to sell 1.95M American Depositary Shares for holders
PremiumThe Fly
Belite Bio files to sell 1.95M American Depositary Shares for holders
20d ago
BLTE
Leerink bullish on Belite Bio, says tinlarebant news another positive data point
PremiumThe Fly
Leerink bullish on Belite Bio, says tinlarebant news another positive data point
27d ago
BLTE
Belite Bio announces China’s NMPA agreed to accept NDA for Tinlarebant
PremiumThe Fly
Belite Bio announces China’s NMPA agreed to accept NDA for Tinlarebant
27d ago
BLTE
Belite Bio price target lowered to $98 from $100 at H.C. Wainwright
PremiumThe Fly
Belite Bio price target lowered to $98 from $100 at H.C. Wainwright
2M ago
BLTE
Promising Outlook for Belite Bio, Inc. Amidst Phase 3 Success and Strong Financial Position
PremiumRatingsPromising Outlook for Belite Bio, Inc. Amidst Phase 3 Success and Strong Financial Position
2M ago
BLTE
Belite Bio completes Phase 3 DRAGON trial of Tinlarebant
Premium
The Fly
Belite Bio completes Phase 3 DRAGON trial of Tinlarebant
2M ago
BLTE
Belite Bio announces up to $250M upsized private placement financing
Premium
The Fly
Belite Bio announces up to $250M upsized private placement financing
2M ago
BLTE
Belite Bio Secures $125 Million in PIPE Financing with Potential for More
PremiumCompany Announcements
Belite Bio Secures $125 Million in PIPE Financing with Potential for More
2M ago
6K
BLTE
Promising Clinical Trials and Strong Financial Position Reinforce Buy Rating for Belite Bio
PremiumRatings
Promising Clinical Trials and Strong Financial Position Reinforce Buy Rating for Belite Bio
3M ago
BLTE
Belite Bio’s Tinlarebant: A Promising Investment with Breakthrough Potential for Stargardt Disease
PremiumRatings
Belite Bio’s Tinlarebant: A Promising Investment with Breakthrough Potential for Stargardt Disease
3M ago
BLTE
Belite Bio’s Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Belite Bio’s Earnings Call: Progress Amid Challenges
3M ago
BLTE
Promising Clinical Trials and Regulatory Advancements Support Buy Rating for Belite Bio, Inc.
PremiumRatingsPromising Clinical Trials and Regulatory Advancements Support Buy Rating for Belite Bio, Inc.
3M ago
BLTE
Belite Bio Advances Retinal Disease Treatments Amid Financial Growth
Premium
Company Announcements
Belite Bio Advances Retinal Disease Treatments Amid Financial Growth
3M ago
BLTE
Belite Bio Announces Q2 2025 Financial Results and Key Clinical Milestones
Premium
Company Announcements
Belite Bio Announces Q2 2025 Financial Results and Key Clinical Milestones
3M ago
6K
BLTE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >